What is the Immunotherapy Cost in India

Immunotherapy is one of the most important cancer treatment methods.

It is majorly used to boost the immune system of a cancer patient and assist the body of the patient to find and kill the cancer cells.

The cost of immunotherapy depends on many factors such as the stage of cancer, type of cancer, and overall health of the patient. 

Immunotherapy cost in India ranges from Rs. 80,000 to Rs. 2,00,000 and may vary depending on various factors.

CityCost in INR
DelhiRs. 80,000 – Rs. 1,30,000
MumbaiRs. 1,50,000 – Rs. 1,60,000
BangaloreRs. 1,00,000 – Rs. 1,30,000
ChennaiRs. 1,30,000 – Rs. 1,50,000 


Take a free opinion from the best cancer doctors for your treatment. You are just one click away, send us your query.

Send Enquiry


Cost of Immunotherapy across the World:

With high-class facilities, like the developed countries and treatment advancements, India provides treatment at an affordable price.

The cost of immunotherapy is lowest in India as compared to other countries.

The list of the cost of immunotherapy in India and different countries is given below: 



immunotherapy cost in different countries


Things to Know About Immunotherapy?

Immunotherapy is a treatment used to tackle tumors using an individual’s own immune system. 

Cancer immunotherapy can activate or alter the way the immune system operates to locate and attack cancer cells. 


doctor checking immunotherapy patients


In the recovery plan, you will schedule for treatment, make good choices about your care, and know how it works and what to expect most.

Immunotherapy is a treatment used to cure illnesses such as tumors in areas of the human immune system. This can be done in a couple of ways:


  • Stimulate or improve the immune system’s normal defenses so that cancer cells locate and attack more or less smartly.

  • Create a laboratory-like material and use it to help repair or boost the way your immune system operates to identify and attack cancer cells.


Send Enquiry


Factors affecting the Cost of Immunotherapy:


The cost of immunotherapy for cancer in India’s best hospitals varies depending on the patient.

The following factors mainly influence immunotherapy costs: 


  • Cancer metastasis:

The extent to which cancer has spread and the organs affected by cancer are the two most important factors in determining immunotherapy costs in India.

If cancer has not spread to other organs, the cost of immunotherapy will be cheaper. 


  • Type of Cancer:

Immunotherapy is not a treatment option for all cancers.

Immunotherapy costs vary depending on the type of cancer.

Immunotherapy type and medications will be determined based on the type of cancer a patient has, eventually determining the cost of immunotherapy in India. 


  • Patient’s health:

Immunotherapy is a treatment in which the immune cells are modified to make them capable of fighting cancer.

As a result, the cost of immunotherapy is heavily influenced by the patient’s overall health. 


  • Time period:

Another important factor in determining the cost of immunotherapy in India is the duration of the treatment.

It depends upon the number of sessions required for immunotherapy.

The period is determined by the following factors, such as the type and stage of cancer. 


  • Treatment plan:

Immunotherapy is not always used alone. A patient may have had chemotherapy, radiation, or surgery first, followed by immunotherapy, raising the overall cost of treatment. 


  • Drugs used:

Different types of medicines are used in immunotherapy, and their prices vary.

The medications used for treatment will be decided by the doctor, which will affect the cost of immunotherapy.


Why Choose Cancer Rounds?


Cancer Rounds is a cancer care provider which offers many benefits to the cancer patient in receiving treatment.

Every patient receives personalised support from our staff throughout their treatment procedure.


why choose cancer rounds


Send us a query and we will help you get a consultation from the best doctors.


Send Enquiry


What are the Side Effects of Immunotherapy? 

There are a few Side effects of immunotherapy that may affect some individuals.

It depends on the type of drug given and the patient’s defence system.

The major cause of these side effects is that the immune inhibitors that are used to attack cancer cells may also affect the normal cells.

Some of the side effects that may hinder the treatment are given below: 


  • Skin complications such as rashes and itching are often observed in people taking immunotherapy treatment for skin cancer or lung cancer. Other types of cancer may also affect the skin cells. 


  • Gastrointestinal tract issues are the most common side effect of immunotherapy. It causes inflammation in the colon and results in diarrhoea, vomiting and nausea. 


  • Apart from that some muscle cramps, swelling in joints and pain in joints are often seen in people. 


  • Kidney and lung problems are rare but can be serious if occur. Some of the symptoms of immunotherapy on the kidney and lungs are coughing, breathing issues or damage to the kidney or kidney failure. 


  • Immunotherapy can cause a decrease in the complete blood cell count and can lead to anaemia and other side effects.  


These side effects may not be observed or experienced by all the patients.

These issues are rare and only affect some patients.

In case, if a patient suffers from any of these side effects, immediately consult your doctor. 


Success Rate of Immunotherapy Treatment

Immunotherapy is a new technology and it assists the patient’s immune system to attack cancer cells.

The success rate of immunotherapy treatment is around 15 to 20 per cent.

The success rate may vary depending upon the type of cancer and the patient’s immune system.  


How does Immunotherapy Work? 

Immunotherapy which is also known as biological therapy is an evolving and modern method of cancer treatment.

Immunotherapy drugs work by supporting the patient’s immune system to destroy cancer cells.

These drugs are either given as CAR T-cell therapy or checkpoint inhibitors which assist in directing the normal healthy immune cells to find and kill the cancerous cells.

It takes around 2 to 3 months after the first session of immune therapy to finally see the response.  


How is Immunotherapy Given to a Patient? 

Immunotherapy can be administered in many ways which include oral, dermal and intravenous routes.

Most commonly it can be given by directly injecting the drugs into the veins as it is the quickest way to administer the drugs.

Apart from that, it can also be applied directly on the skin in cream format.

Both methods are the quickest way possible to take immunotherapy as they also eliminate the first pass metabolism.

The other way is to swallow pills or drugs. Depending upon the type of cancer, the doctor may decide how immunotherapy should be given. 


Types of Cancer Treated with Immunotherapy:

Immunotherapy has been a significant aspect of the treatment of many forms of cancer in recent decades. 

New therapies for immunotherapy are tried and embraced, and new methods of dealing with the immune system are very soon found.

In some tumors, immunotherapy performs better than in other therapies.

In the treatment of certain forms of cancer, immunotherapy has proved useful.

Various forms of cancer that may be treated with immunotherapy include prostate cancer, skin cancer, kidney cancer, bladder cancer, lymphoma, and cancer of the head and neck. 

Some research findings indicate that immunotherapy showed a 20-30 percent good effect on the patients that were not as commonly used as radiation treatment, operation, or chemotherapy.

Doctors prescribe for the first and second-line therapies if the patient’s body fails.


1. Immunotherapy for Breast Cancer

Breast cancer immunotherapy is progressing quickly as recent trials show better results in breast cancer subsets.

Typically, existing approaches for the treatment of breast cancer require surgery if the condition is detected early. 

Breast cancer treatment can include chemotherapy, hormone therapy, surgery, and/or radiation, depending on the stage and molecular characteristics of cancer when diagnosed.


breast cancer


While immunotherapy has long been considered difficult to treat breast cancer because it is immunologically “cold,” some recent preclinical and clinical trials also show that immunotherapy care has the ability for patients with breast cancer to enhance results.

In March 2019, for the treatment of triple-negative, metastatic breast cancer in patients whose tumors express the PD-L1 antibody, the FDA approved the first checkpoint immunotherapy inhibitor, an anti-PD-L1 antibody called atezolizumab (Tecentriq®), in conjunction with chemotherapy.


2. Immunotherapy for lung Cancer

It will greatly change outcomes for patients battling lung cancer, alone or in conjunction with traditional therapies.

Until recently, surgery, chemotherapy, and radiation were traditional treatment methods for lung cancer.

Since most patients with lung cancer are diagnosed with advanced disease (stage 3b/4), it is unlikely that these therapies can result in total cures, while recovery can be greatly increased and symptom relief can be given.


lung cancer tumor


In the U.S. in 2015 The first immunotherapy to treat a subset of patients with lung cancer was approved by the FDA. Immunotherapy is a form of medication that seeks to suppress or regulate cancer from a person’s own immune system. 

Latest clinical trials in the treatment of patients with immunotherapy, either alone or in conjunction with other drugs, have shown substantial patient progress, leading to the acceptance by the FDA of many more immunotherapy alternatives for more patients with lung cancer, including patient treatment approvals to treat patients with immunotherapy as a first-line therapy instead of conventional treatments.


3. Immunotherapy for Liver Cancer

Liver cancer immunotherapy may boost the response of the cancer-fighting immune system, but may not always be available or possible in patients with a history of hepatitis infection.

Surveillance, surgery, liver replacement, ablation therapy, embolization therapy, targeted therapy, and radiation therapy are common therapies for liver cancer.


liver cancer


For advanced HCC, the immunotherapy regimen of the control point inhibitor atezolizumab and the targeted antibody bevacizumab is the quality of treatment.

Immunotherapy is a form of treatment that helps destroy cancer cells by taking advantage of a person’s own immune system. Three FDA-approved immunotherapy options for liver cancer currently exist.


4. Immunotherapy for Prostate Cancer

Prostate cancer immunotherapy provides two FDA approved treatment options and is a promising area of study for the treatment of metastatic cancer.


prostate cancer


Conventional therapies include surgery and radiation for early-stage prostate cancer.

Hormonal therapy is also used to treat early-stage cancers and may reduce the levels of male hormones (androgens, such as testosterone) that contribute to tumor development.

Chemotherapy is also a treatment choice for advanced or metastatic prostate cancer.

Immunotherapy is a form of treatment that helps destroy cancer cells by taking advantage of a person’s own immune system. For prostate cancer, there are currently two FDA-approved immunotherapy options.


5. Immunotherapy for Pancreatic Cancer

Pancreatic cancer immunotherapy is now in clinical trials, supplying people with this difficult-to-treat cancer with possible alternative options.

Surgical resection, radiation, ablative procedures, and chemotherapy are common methods for pancreatic cancer.

Actually full surgical removal of the pancreas, a surgery for which less than 20 percent of those affected are eligible, is the only cure for pancreatic cancer that has any chance of preventing the patient’s disease.


pancreatic cancer


Ultimately, even patients who do stick with surgery will rebound, leading to the immediate need for more successful therapies that are more likely to avoid future relapse.

Immunotherapy is a form of treatment that helps destroy cancer cells by taking advantage of a person’s own immune system. For a limited subset of patients with pancreatic cancer, there is currently one FDA-approved immunotherapy alternative, and several more are being studied in clinical trials.


Send Enquiry

Related Posts

Contact Us

    Mobile Number